Copper-ATSM Prevented Motor Neuron Loss in SALS Mouse Model
Copper-ATSM — a compound originally used as an imaging agent — prevented motor neuron loss and reduced brain inflammation…
Articles by Marisa Wexler, MS
#AANAM — Research Examines Clinical, Genetic Features of ALS Type 4
New research details some of the clinical and genetic changes and imaging features seen in patients with amyotrophic lateral…
#AANAM – Art Therapy Can Improve Psychological Well-Being In ALS Patients, Study Reports
Making digital art can be beneficial for the psychological health of people with amyotrophic lateral sclerosis (ALS), a proof-of-concept study…
#AANAM — Leukemia Therapy May Also Treat ALS, Mouse Study Suggests
A cancer therapy called imatinib mesylate (sold under the brand name Gleevec) has the potential to slow progression in…
#AANAM — Radicava May Limit Functional Decline in ALS Patients, Review Study Suggests
Radicava (edaravone) may prevent functional deterioration in amyotrophic lateral sclerosis (ALS) patients, results from a literature review suggest.
ALS Patients with Parkinsonian Symptoms Have Differences in Brain Activity, Study Finds
As many as a third of people with amyotrophic lateral sclerosis (ALS) also have symptoms of Parkinson’s disease,…
ALS Mutation Affects Key Pathway, But Asthma Treatment Seen to Offer Protection in Early Study
A possible new target for treating amyotrophic lateral sclerosis (ALS) may be the nonsense-mediated mRNA decay (NMD) pathway, which helps cells…
Certain Blood Markers Linked to Different Stages of ALS, Study Suggests
Differences in blood parameters, such as total protein levels, are associated with different stages of amyotrophic lateral sclerosis (ALS), meaning…